TY - GEN AU - Wei,Zheng AU - Zou,Shanhua AU - Li,Feng AU - Cheng,Zhixiang AU - Li,Junmin AU - Wang,Jianmin AU - Wang,Chun AU - Chen,Fangyuan AU - Cao,Junning AU - Cheng,Yunfeng TI - HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China SN - 1559-131X PY - 2014///0930 KW - Antibodies, Monoclonal, Murine-Derived KW - administration & dosage KW - Antineoplastic Combined Chemotherapy Protocols KW - therapeutic use KW - China KW - Cyclophosphamide KW - Doxorubicin KW - Female KW - Follow-Up Studies KW - Hepatitis B KW - complications KW - Hepatitis B Surface Antigens KW - metabolism KW - Hepatitis B virus KW - genetics KW - Humans KW - Lymphoma, Large B-Cell, Diffuse KW - drug therapy KW - Male KW - Middle Aged KW - Neoplasm Staging KW - Prednisone KW - Prognosis KW - Retrospective Studies KW - Rituximab KW - Survival Rate KW - Vincristine N1 - Publication Type: Journal Article; Multicenter Study UR - https://doi.org/10.1007/s12032-014-0845-3 ER -